Menu Close

Trending

Roche, Boehringer tap biosensor firms for patient studies
A new dawn of the genomic age: five areas set to be transformed in 2023
ABPI code updated with first social media guidance
NICE recommends first CAR-T cell therapy on NHS in England
EU clears Enhertu for HER2-low breast cancer

healthcare events

 
Print

Debates/ R&D/ Webinars/ Webinars in home page/ Webinars On demand

The new global digital health paradigm in life sciences

, , , , , , 0 Comment

Digital transformation has long been a priority for all life science companies and it has been made even

X
The new global digital health paradigm in life sciences
https://pharmaphorum.com/r-d/10-years-in-10-days-the-new-global-digital-health-paradigm-in-life-sciences/
Coronavirus-Conference-Update

Sales and Marketing/ Views & Analysis/ Views and analysis

Coronavirus pharma conference monitor – event impact of COVID-19

, , , , 0 Comment

The COVID-19 coronavirus epidemic that originated in Wuhan, the capital of China’s Hubei province, has wide-ranging implications for

X
Coronavirus pharma conference monitor – event impact of COVID-19
https://pharmaphorum.com/views-and-analysis/coronavirus-pharma-conference-monitor/
 
Ashfield-webinar-Image-16x9-Text

Debates/ Debates & Insight/ Debates & Insight/ Market Access/ Sales and Marketing/ Webinars in home page/ Webinars On demand

Engaging with HCPS: what do HCPs want from medical meetings?

, , , , , , , , , 0 Comment

There has been a myriad of reasons over the past few years to safely assume the popularity and

X
Engaging with HCPS: what do HCPs want from medical meetings?
https://pharmaphorum.com/webinars/webinars-on-demand/engaging-with-hcps-what-do-hcps-want-from-medical-meetings/

Login

CONTINUE TO SITE >
X
Close in 10 seconds